Amneal Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.About AMRX
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.
CEOChintu Patel
CEOChintu Patel
Employees8,300
Employees8,300
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2002
Founded2002
Employees8,300
Employees8,300
AMRX Key Statistics
Market cap2.57B
Market cap2.57B
Price-Earnings ratio1.18K
Price-Earnings ratio1.18K
Dividend yield—
Dividend yield—
Average volume1.53M
Average volume1.53M
High today$8.21
High today$8.21
Low today$8.01
Low today$8.01
Open price$8.04
Open price$8.04
Volume1.16M
Volume1.16M
52 Week high$9.48
52 Week high$9.48
52 Week low$6.69
52 Week low$6.69
AMRX News
Seeking Alpha 2d
Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerateEarnings Call Insights Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate Aug. 05, 2025 2:57 PM ET Amneal Pharmac...
Seeking Alpha 3d
Amneal Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.08, revenue of $725M misses by $19.56MEarnings News Amneal Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.08, revenue of $725M misses by $19.56M Aug. 05, 2025 6:08 AM ET Amneal Pharmaceuticals, I...
People also own
Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.